Adbiotech Co. Ltd.
ADBiotech Co., Ltd. develops and sells antibodies for livestock, fisheries, and humans in South Korea and internationally. The company offers antibiotic, disinfectant, helminthic, over the counter drugs, supplementary feed, and metabolic drugs. It also offers health functional and processed foods. ADBiotech Co., Ltd. was founded in 2000 and is based in Chuncheon-si, South Korea.
Market Cap & Net Worth: Adbiotech Co. Ltd. (179530)
Adbiotech Co. Ltd. (KQ:179530) has a market capitalization of $15.19 Million (₩22.24 Billion) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #30117 globally and #2024 in its home market, demonstrating a 12.05% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Adbiotech Co. Ltd.'s stock price ₩1757.00 by its total outstanding shares 12656308 (12.66 Million).
Adbiotech Co. Ltd. Market Cap History: 2022 to 2026
Adbiotech Co. Ltd.'s market capitalization history from 2022 to 2026. Data shows change from $29.04 Million to $15.19 Million (-25.49% CAGR).
Index Memberships
Adbiotech Co. Ltd. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.85 Billion | 0.00% | #1118 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.85 Billion | 0.00% | #1118 of 1384 |
Weight: Adbiotech Co. Ltd.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Adbiotech Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Adbiotech Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Adbiotech Co. Ltd.'s market cap is 0.00 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $29.04 Million | $10.63 Billion | $2.70 Billion | 0.00x | 0.01x |
| 2023 | $28.31 Million | $10.47 Billion | -$2.86 Billion | 0.00x | N/A |
| 2024 | $17.98 Million | $11.14 Billion | -$7.95 Billion | 0.00x | N/A |
Competitor Companies of 179530 by Market Capitalization
Companies near Adbiotech Co. Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to Adbiotech Co. Ltd. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Adbiotech Co. Ltd. Historical Marketcap From 2022 to 2026
Between 2022 and today, Adbiotech Co. Ltd.'s market cap moved from $29.04 Million to $ 15.19 Million, with a yearly change of -25.49%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩15.19 Million | -13.45% |
| 2025 | ₩17.55 Million | -2.40% |
| 2024 | ₩17.98 Million | -36.49% |
| 2023 | ₩28.31 Million | -2.53% |
| 2022 | ₩29.04 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Adbiotech Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $15.19 Million USD |
| MoneyControl | $15.19 Million USD |
| MarketWatch | $15.19 Million USD |
| marketcap.company | $15.19 Million USD |
| Reuters | $15.19 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.